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Abstract
 
The molecular basis of how 
 
Borrelia burgdorferi
 
 (
 
Bb
 
), the Lyme disease spirochete, maintains itself
in nature via a complex life cycle in ticks and mammals is poorly understood. Outer surface
(lipo)protein A (OspA) of 
 
Bb
 
 has been the most intensively studied of all borrelial molecular
constituents, and hence, much has been speculated about the potential role(s) of OspA in the
life cycle of 
 
Bb
 
. However, the precise function of OspA (along with that of its close relative
and operonic partner, outer surface [lipo]protein B [OspB]) heretofore has not been directly
determined, due primarily to the inability to generate an OspA/B-deficient mutant from a
virulent strain of 
 
Bb
 
. In this study, we created an OspA/B-deficient mutant of an infectious
human isolate of 
 
Bb
 
 (strain 297) and found that OspA/B function was not required for either 
 
Bb
 
infection of mice or accompanying tissue pathology. However, OspA/B function was essential
for 
 
Bb
 
 colonization of and survival within tick midguts, events crucial for sustaining 
 
Bb
 
 in its
natural enzootic life cycle.
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Introduction
 
Lyme disease is the most prevalent arthropod-born infection
in the United States (1). The agent of Lyme disease, 
 
Borrelia
burgdorferi
 
 (
 
Bb
 
), maintains itself in nature via a complex life
cycle involving ticks and mammals (2). Since the discovery
of the etiological agent, outer surface (lipo)protein A (OspA)
has been a central focus of Lyme disease research (3, 4).
OspA (a) has comprised the first Lyme disease vaccine (5), (b)
represents a paradigm of differential lipoprotein expression
(6–8), (c) has been implicated in the late sequelae (chronic
arthritis) of Lyme disease (9), and (d) has been crystallized
(10). OspA is abundantly expressed by 
 
Bb
 
 within the midguts
of unfed ticks but is down-regulated in 
 
Bb
 
 as ticks take a
blood meal and as borreliae are transmitted to the mammalian
host (6–8). These observations have led to speculation that
OspA may be involved in some aspect(s) of the tick phase of
 
Bb
 
’s life cycle (11, 12). Subsequent studies have postulated
that OspA may promote tick colonization, in that purified
recombinant OspA bound to extracts of tick midgut cells
(13) and adherence of 
 
Bb
 
 to tick midgut epithelium was
markedly reduced in the presence of OspA antibodies (14).
Despite these intensive efforts, direct evidence to demon-
strate a role for OspA either in the tick-born or mammalian
phase of 
 
Bb
 
’s life cycle heretofore has been lacking (11).
A major obstacle to defining the function of OspA has
been that virulent strains of 
 
Bb
 
 are refractory to genetic
manipulation (15, 16), thereby hindering the generation of
OspA-deficient mutants of the spirochete. Producing such
OspA-deficient variants is essential for establishing a causal
relationship between OspA and any given phenotype.
Recent successes in genetically manipulating virulent 
 
Bb
 
and the development of new shuttle vectors (17–22)
prompted renewed efforts to generate an OspA-deficient
mutant. In an effort to satisfy “molecular” Koch’s postu-
lates (23), in the current study an OspA/B-deficient mutant
of 
 
Bb
 
 297 and genetically complemented strains were gen-
erated and examined for phenotypic traits pertaining to
mouse infectivity, pathogenicity, and their colonization of
and transmission by 
 
Ixodes scapularis
 
 ticks.
 
The online version of this article includes supplemental material.
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Materials and Methods
 
Bacterial Strains and I. scapularis.
 
An infectious clone of 
 
Bb
 
,
BbAH130, was recovered after plating 
 
Bb
 
 strain 297 (297) on
Barbour-Stoenner-Kelly (BSK) agar medium. The clone was
then needle inoculated (intradermally) into mice and recovered
from cultures of ear punch biopsies. BbAH130 possesses all 21 of
the parental plasmids (determined by PCR) found in strain 297
(19) and is infectious for mice. 
 
Bb
 
 strain 48081, lacking the lp54
plasmid (24), was provided by John F. Anderson (Connecticut
Agricultural Experimental Station, New Haven, CT). Borreliae
were cultivated in vitro in BSK-H liquid medium at 37
 
 
 
C
(Sigma-Aldrich). 
 
Escherichia coli
 
 strain TOP 10 (Invitrogen) was
used as a cloning host. Adult female 
 
I. scapularis
 
 ticks were col-
lected in Connecticut as a source of eggs. The egg masses were
laid in the laboratory. Hatched larvae were allowed to feed on
pathogen-free C3H/HeN mice to produce sterile nymphs. The
absence of bacteria in nymphs was verified by performing dark
field microscopy on midgut contents from several ticks within
each reared colony. All tick rearing was performed in an incuba-
tor at 26
 
 
 
C with 85% relative humidity and using a controlled
light–dark photoperiod.
 
Construction of Suicide Plasmids.
 
All recombinant DNA exper-
iments and the use of antibiotic resistance markers in strain 297
were reviewed and approved by the University of Texas South-
western Medical Center Biological and Chemical Safety Advisory
Committee. A 4-kb DNA fragment containing 
 
ospAB
 
 (genes
BBA15 and BBA16) with flanking sequence was obtained by
PCR amplification from 297 genomic DNA. PCR was per-
formed by using the Expand High Fidelity PCR System (Roche
Diagnostics). The primer design was based on published gene se-
quences for 
 
Bb
 
 strain B31 (25) (primers 1 and 2; Table S1, avail-
able at http://www.jem.org/cgi/content/full/jem.20031960/
DC1). The PCR fragment was then cloned into the pCR-XL-
TOPO cloning vector (Invitrogen). The resulting plasmid was
designated as pXT-OspAB. Then, an 
 
aadA
 
 cassette (which con-
fers streptomycin [Strep] resistance to 
 
Bb
 
 [26]) was inserted at the
 
Acc
 
I site within the 
 
ospA
 
 gene, resulting in plasmid pXT-OspAB-
Strep (Fig. 1 A). To generate the 
 
ospAB
 
 mutant, 20 
 
 
 
g of pXT-
OspA-Strep plasmid DNA was electroporated into BbAH130.
The transformation mixture was then diluted into 100 ml of
BSK-H medium. After overnight recovery, Strep was added to
the transformation mixture at a final concentration of 50 
 
 
 
g/ml,
and the mixtures were aliquotted into multiple 96-well tissue
culture plates (200 
 
 
 
l/well). 2–3 wk after plating, the wells that
contained positive cultures were identified by color change of the
medium; the presence of viable spirochetes subsequently was ver-
ified by dark field microscopy. In general, 
 
 
 
10% of microtiter
plate wells contained positive cultures, suggesting that each well
culture was clonal in origin. PCR amplification with various
primer pairs (Table S1) was performed on whole cell lysates of
these transformants to verify that the streptomycin-resistance
 
(
 
Strep
 
r
 
) transformants contained the appropriate 
 
aadA
 
 insertion
(Fig. 1). Although highly unlikely, the possibility that the suicide
plasmid inserted into more than one site would not have influ-
enced our studies because the mutant remained infectious and
complementation was successful in restoring OspA/B function
(see Results and Discussion). Also, plasmid contents of the
OspA/B
 
  
 
mutants were examined by PCR as described previ-
ously (19, 27, 28).
 
Complementation of the OspA/B
 
 
 
 Mutant.
 
To complement
the OspA/B
 
 
 
 mutant with a wild-type copy of 
 
ospAB
 
, a 2-kb
DNA fragment containing the wild-type 
 
ospAB
 
 genes first was
PCR amplified from 
 
Bb
 
 strain 297 using primers 3 and 4 (Table
S1). This fragment subsequently was cloned into pCR-XL-
TOPO (Invitrogen), resulting in plasmid pXT-ospAB-2kb.
pXT-ospAB-2kb was then digested with SacI and XbaI, and the
2-kb fragment containing the 
 
ospAB
 
 genes was inserted into the
corresponding sites of pBSV2 (22) (provided by Philip E. Stew-
art and Patricia Rosa, National Institutes of Health Rocky
Mountain Laboratories, Hamilton, MT). The resulting plasmid
was designated pOspA/B (see Fig. 6 A). To complement the
OspA/B
 
 
 
 mutant with only wild-type 
 
ospA
 
, pOspA/B was di-
gested with 
 
Asp
 
E1 and 
 
Bst
 
Ap1 (cleaving within the 
 
ospB
 
 gene).
The linear plasmid with the 
 
ospB
 
 deletion was then blunt ended
and ligated closed, culminating in plasmid pOspA. For comple-
mentation, 20 
 
 
 
g of pOspA/B or pOspA DNA was electropo-
rated into the OspA/B
 
 
 
 mutant, and 
 
 
 
20 kanamycin-resistant/
Strep
 
r
 
 clones were obtained. To confirm that these clones con-
tained the pOspA/B or pOspA plasmid, whole cell lysates of
kanamycin-resistant/Strep
 
r
 
 cells were used to transform TOP10
 
E. coli
 
. Plasmid was then rescued from these 
 
E. coli
 
 transformants,
and restriction digestions were performed to verify recovery of
the respective plasmid.
 
Bb Infection of Mice via Needle Inoculation.
 
Groups of five 3-wk-
old C3H/HeN mice (Jackson Laboratories) were needle inoc-
ulated (intradermally) with either 10
 
2
 
, 10
 
3
 
, or 10
 
4
 
 wild-type 297 or
OspA/B
 
 
 
 mutants. 3 wk later, tibiotarsal and knee joints were
evaluated for swelling (29). Ear punch biopsies were taken and cul-
tured in BSK-H medium at 37
 
 
 
C. Skin, hearts, and joint tissues also
were harvested for DNA extraction. Joint tissues were additionally
subjected to histopathology analysis and were scored in blinded
fashion; ranking was performed on the basis of relative degrees of
leukocyte and fibrin exudation and synovial proliferation (29).
 
Transmission of Bb from Infected Mice to Sterile Ticks.
 
To study
the transmission of various 
 
Bb
 
 strains from mice to ticks, naive
nymphal forms of 
 
I. scapularis
 
 were allowed to feed on 
 
Bb
 
-
infected (needle inoculated) mice. Actively feeding nymphs were
forcibly detached from the skin of mice at 12-h intervals after the
onset of attachment. Other nymphs were allowed to feed to re-
pletion and detach naturally from the mice; these nymphs were
collected at 24-h intervals for up to 96 h postfeeding. Midguts
from each group of nymphs were microscopically dissected in the
presence of PBS. The midgut luminal contents (including the
blood meal) and the midgut tissues that were washed with PBS to
ensure the removal of luminal contents were isolated and sub-
jected to immunofluorescence confocal microscopy (13). Spiro-
chetes in the samples were then enumerated microscopically as
described previously (13, 14).
 
Microinjection of Bb into Ticks.
 
A microinjection delivery sys-
tem was developed and used to introduce spirochetes into the gut
of 
 
I. scapularis
 
 nymphs. For microinjection, each 
 
Bb
 
 variant was
cultivated under normal conditions in BSK-H medium in the
presence or absence of selective antibiotics. Bacteria were har-
vested by centrifugation and concentrated in fresh BSK-H me-
dium to a density of 10
 
9
 
 spirochetes per ml. 10 
 
 
 
l of the cell sus-
pension was then loaded into a 1-mm diameter glass capillary
needle (World Precision Instruments Inc.) using a microloader
(Eppendorf AG). Unfed nymphs were attached with the ventral
side facing up onto a glass slide using double-sided tape. With the
aid of a stereo-dissecting binocular microscope, tips of the capillary
needles harboring the spirochete suspension were carefully inserted
into the rectal aperture through forced opening of the rectal valves;
the suspension was then injected into the tick using a femtojet mi-
croinjector system (Eppendorf AG). The parameters for injection
were a pressure of 1,000 hPa, injection time of 1 s, and a compen- 
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sation pressure of 8 hPa. After microinjection, ticks were reared at
room temperature in a humid chamber for 24–72 h. Groups of
ticks were killed and assessed for spirochete content by dark field
microscopy, culture, and RT-PCR analysis. Groups of ticks with
spirochete infection efficiencies of nearly 100% were then used for
further colonization evaluations.
 
PCR, RT-PCR, and Real-Time PCR.
 
Total RNA from
wild-type BbAH130 or mutants was isolated using the Nu-
cleoSpin RNA II purification kit (BD Biosciences) according to
instructions provided by the manufacturer. RT-PCR reactions
for amplification of 
 
ospA
 
 and 
 
flaB
 
 transcripts were performed us-
ing 
 
 
 
50 ng of total RNA, pertinent oligonucleotide primers, and
the Titan One Tube RT-PCR System (Roche Diagnostics).
For RT-PCR analysis of 
 
Bb
 
 RNA in ticks, total RNA was iso-
lated from 
 
I. scapularis
 
 using the NucleoSpin II RNA isolation kit
(CLONTECH Laboratories Inc.). 2 
 
 
 
g of total RNA was con-
verted to cDNA using ProSTAR first strand RT-PCR kit (Strata-
gene) with random hexamers. The cDNA was then used for
PCR amplification of 
 
flaB
 
 using oligonucleotide primers 7 and 8.
In selected tubes, RT-PCR was conducted without the addition
of reverse transcriptase to ensure the absence of DNA contamina-
tion. An aliquot of the RT-PCR product was analyzed on a 1.5%
agarose gel. As an internal control, primers 5 and 6 (Table S1)
were used to amplify tick 
 
 
 
-actin mRNA (GenBank/EMBL/
DDBJ accession no. AF426178).
For quantitative analysis of 
 
Bb
 
 loads in mouse tissues, real-time
PCR was performed to detect 
 
Bb
 
 
 
flaB
 
. To accomplish this, total
DNA was isolated from the skin, hearts, or joints of infected mice
using the DNAeasy kit (QIAGEN). 70-bp 
 
flaB
 
 amplicons were
quantitated using oligonucleotide primers 9 and 10 and a labeled
probe (primer 11). The DNA samples were then subjected to se-
rial 10-fold dilutions added to a 50-
 
 
 
l reaction mixture contain-
ing 0.2 
 
 
 
M of primers and probe. PlatinumTaq (Invitrogen) in
the presence of 2 mM MgSO
 
4
 
 was used to perform the thermal
cycling as follows: 95
 
 
 
C for 4 min, 40 cycles of 95
 
 
 
C for 15 s, and
60
 
 
 
C for 1 min. Standard curves for 
 
flaB
 
 were prepared using 10-
fold serial dilutions of known quantities (10 ng to 0.1 fg) of 
 
Bb
 
DNA or the plasmid pCR 2.1
 
–
 
 
 
-actin
 
. Equal amounts of mouse
DNA were then used for measuring levels of 
 
Bb
 
 flaB.
Antibodies, Antisera, and Protein Analyses. Monoclonal anti-
bodies (14D2–27 and 8H3–33) directed against OspA and FlaB,
respectively, were reported previously (30). Rat polyclonal anti-
sera directed against OspB was described previously (31). SDS-
PAGE and immunoblotting were performed as reported (30).
Online Supplemental Material. Table S1 (available at http://
www.jem.org/cgi/content/full/jem.20031960/DC1) shows oli-
gonucleotide primers used in this study.
Results and Discussion
Generation of the OspA/B-deficient Mutant. ospA and its
downstream operonic partner ospB are encoded on the 54-
kb linear plasmid (lp54) (25). OspA and OspB are 53%
identical and 63% similar, suggesting that these two lipopro-
teins arose from a gene duplication event. OspB also has the
same temporal and topological (membrane) expression pat-
tern as OspA (32), and thus OspA and OspB likely perform
similar, if not identical, physiological function(s). Therefore,
to ensure that a particular borrelial phenotype could be at-
tributed to a complete loss of function, our strategy for cre-
ating an ospA-deficient mutant of Bb included inactivating
the entire ospAB operon. The generation of such ospAB
mutants appeared feasible given that “escape” mutants lack-
ing the ospAB genes have been isolated from high passage,
noninfectious strains of Bb after treatment with OspA or
OspB bactericidal antibodies (33, 34).
To create an ospAB mutant from the infectious 297
strain of Bb, we first constructed a suicide vector containing
the  ospAB operon disrupted by insertion of the Strepr
marker, aadA, into ospAB (26) (Fig. 1 A). Because it has
been noted that noninfectious “escape” mutants of Bb lack-
ing OspA/B expression (isolated after antibody selection in
vitro) aggregate and have reduced plating efficiency on
semisolid medium (35), we modified the established proto-
col for Bb transformation (36) by first diluting the transfor-
mation mixture in BSK-H liquid medium and then ali-
quoting it into 96-well tissue culture plates. Strepr cultures
arising from individual clones were readily obtained in
these wells (indicated by color change of the medium).
Subsequent plating revealed that, in comparison with wild-
type 297, these clones were severely impaired for growth
on semisolid pBSK agar medium, a condition that likely
contributed to past failures to isolate OspA-deficient mu-
tants of infectious strains of Bb. Of note, the method of
plating the transformation mixture into 96-well plates has
increased our efficiency in obtaining many other types of
Bb mutants. Further analyses of the Strepr clones indicated
that they contained the appropriate aadA marker insertion
within ospAB (Fig. 1 B) and did not produce either OspA
Figure 1. Construction of the OspA/B  mutant of Bb. (A) Strategy for
insertional (aadA) inactivation of the ospAB operon. The top line diagram
denotes the suicide plasmid (pXT-OspAB-Strep) used for transformation
into Bb and subsequent homologous recombination (double crossover)
with the wild-type (WT) genome in Bb. Only the relevant portions of
the plasmid and genome are shown. Arrows denote positions of oligonu-
cleotide primers used for PCR. (B) PCR analysis of Bb variants. Letter
combinations denote primer pairs used for PCR. 1, wild-type Bb; 2, the
OspA/B  mutant; 3, spirochetes recovered from mice infected with the
OspA/B  mutant.Function of OspA 644
or OspB (Fig. 2, A and B, lanes 2). Because infectious Bb
tends to lose its endogenous plasmids upon in vitro cultiva-
tion and genetic manipulation, we screened each clone by
PCR for plasmid content. Most clones had plasmid profiles
identical to parental (wild-type) 297, although some lacked
cp9 (nonessential). One clone containing the full comple-
ment of plasmids was chosen for further study.
Influence of OspA/B Deficiency on Bb Infectivity for Mice.
To examine a potential role for OspA/B in the infectious
phenotype of Bb, groups of five C3H/HeN mice were in-
oculated intradermally with varying numbers (105, 104, 103,
or 102) of either the OspA/B-deficient mutant (OspA/B )
or wild-type 297. 2 wk after injection, ear punch biopsies
were harvested and cultured in BSK-H medium (absent an-
tibiotic selection). Both wild-type 297 and OspA/B  spiro-
chetes were readily observed in all cultures of ear punch bi-
opsies, indicating that wild-type 297 and the mutant had
similar infectious phenotypes. Further analyses indicated
that the OspA/B  mutant maintained its mutant genotype
and phenotype after recovery from mice (Fig. 2 A–C, lanes
3). To further assess tissue dissemination by the OspA/B 
mutant, we next used quantitative PCR for flaB as a surro-
gate indicator of spirochete loads in mouse skin, joints, and
hearts. Mice infected with the OspA/B  mutant had similar
(skin and heart) or even higher (joint) levels of spirochetes
when compared with mice infected by wild-type 297 (Fig.
3 A). Further analysis of joint swelling and histopathology
(29) revealed that the OspA/B  mutant elicited arthritis
more pronounced than that induced by wild-type 297 (Fig.
3 B), perhaps as a consequence of the higher numbers of
spirochetes detected in joints (Fig. 3 A) (37). Nonetheless,
the combined data indicated that OspA/B function is not
essential for Bb infection, replication, dissemination, or
pathogenesis in the murine model of Lyme borreliosis.
It is well established that Bb down-regulates the expres-
sion of OspA and OspB during its transmission into mam-
malian hosts (7, 8). This observation has given rise to the
hypothesis that OspA/B function may not be required for
the early event(s) of mammalian infection. Our data pro-
vide the first direct evidence that OspA/B is not essential
for either early stage mammalian infection or pathogenicity
by  Bb. However, our results do not exclude a role for
OspA in the pathogenesis of late stage Lyme disease. In this
regard, it has been shown that patients with late stage Lyme
disease have detectable levels of serum OspA antibodies
(38), suggesting that OspA may be expressed by Bb late in
the course of infection. Further studies have revealed that
an immunodominant T cell epitope of OspA is homolo-
gous to a sequence within human leukocyte function–asso-
ciated antigen-1, implying that autoimmunity induced by
OspA may, in part, drive the clinical sequelae of chronic
(treatment-resistant) Lyme arthritis (9). Because there is no
murine model of chronic Lyme arthritis, the possible con-
tribution of OspA to the development of chronic Lyme ar-
thritis could not be addressed in our studies but warrants
further investigation.
Influence of OspA/B Deficiency on Bb’s Ability to Colonize
Ticks. The availability of the OspA/B-deficient mutant of
infectious Bb made it possible to assess directly the influ-
ence of the OspA/B deficiency on the natural transmission
of Bb from infected mice to I. scapularis ticks. To accom-
plish this, sterile nymphs were allowed to feed on mice 3
wk after infection (needle inoculation) with either wild-
type 297 or the OspA/B  mutant (same group of mice
used in Fig. 3). Nymphs were forcibly removed from mice
every 12 h during the feeding phase (generally lasting 72–
96 h). After the feeding phase, naturally detached ticks
were collected at 24-h intervals for an additional 96-h post-
feeding. Tick midgut luminal contents (including the blood
meal) as well as midgut tissues washed free of luminal con-
tents were isolated and subjected to immunofluorescence
confocal microscopy. In ticks that fed on wild-type spiro-
chete-infected mice, bacteria were first detected in tick
midgut tissue samples at 48 h of tick feeding. At 72 h of
tick feeding, striking numbers of wild-type spirochetes
were associated with tick midgut tissues (Fig. 4 A). In con-
trast, spirochetes were not observed in midgut tissue sam-
ples of ticks that fed on OspA/B -infected mice (Fig. 4 A),
suggesting that the mutant was defective in tick midgut
colonization. This defect could not be attributed to a defi-
ciency in transmission from the mouse to the tick, inas-
Figure 2. Characterization of the OspA/B  mutant of Bb. (A) SDS-
PAGE, (B) immunoblot, and (C) RT-PCR analyses of wild-type 297
(lanes 1), OspA/B  mutant (lanes 2), and the OspA/B  mutant recovered
from mice needle inoculated with the OspA/B  mutant (lanes 3).   and  ,
with or without reverse transcriptase (RT), respectively. flaB transcription
was assessed as an internal control.
Figure 3. Characterization of
the OspA/B  mutant in the mu-
rine model of Lyme borreliosis.
(A) Quantitative PCR assessment
of spirochete loads in mouse tissues
3 wk postinfection; units on the
y-axis are fg of flaB DNA per  g
of mouse tissue DNA. (B) Quanti-
tative  assessment of arthritis in
infected mice. Arthritis was eval-
uated on a scale of 0–3 (absent,
mild, moderate, or severe) for
joint swelling and exudation of
fibrin and leukocytes into joint
spaces, synovial thickening due
to proliferation, and hypertrophy
of synovial cells. Both tibiotarsal
and knee joints were examined
in each animal.Yang et al. 645
much as the OspA/B  mutant was readily detected in the
blood meal at levels comparable to those of wild-type 297
(Fig. 4 A); this finding was supported by RT-PCR (for flaB
transcripts) of total RNA from parallel groups of ticks (Fig.
4 B). Furthermore, RT-PCR confirmed that ospA tran-
scripts were not detectable from ticks fed on OspA/B -
infected mice (Fig. 5). In the postfeeding phase, wild-type
spirochetes, but not the OspA/B  mutant, again were
found associated with tick midgut tissues (Fig. 4 A). How-
ever, in contrast to blood meal results obtained from the
feeding ticks, OspA/B  spirochetes were not detected in
the blood meals of postfeeding ticks (Fig. 4 A). Additional
RT-PCR analyses corroborated this finding (Fig. 4 B).
Thus, the combined findings of Fig. 4, A and B, suggest
that although the OspA/B  mutant was transmissible from
mouse tissues to tick midguts, it failed to colonize tick mid-
gut tissue. Furthermore, a particularly surprising finding
was the inability of the OspA/B  mutant to survive (even
at 48 h postfeeding) within tick midguts, a key niche for Bb
in nature.
That the OspA/B  mutant was defective in tick midgut
tissue colonization could have been due to suboptimal lev-
els of mutant spirochetes transmitted to the tick gut or a
general inability of the mutant to survive for any significant
period of time in ticks. To address these possibilities, as op-
posed to using the more conventional capillary feeding
(39), we chose a direct microinjection approach that could
be more easily controlled. With this new method, it is pos-
Figure 4. Detection of wild-type or
OspA/B  spirochetes in ticks by (A) confocal
microscopy or (B) RT-PCR. I. scapularis
nymphs feeding on mice infected previously
with either wild-type 297 (WT) or the
OspA/B  mutant were removed from mice
every 12 h; after this feeding phase, naturally
detached ticks were collected at 24-h intervals.
Tick midgut luminal contents (including
the blood meal) and midgut tissues washed
free of luminal contents were then isolated.
Red denotes tick tissues or blood cells;
green indicates spirochetes. Amplicons of
flaB transcripts were used to signify the
presence of spirochetes; tick  -actin was
used as an internal control for RT-PCR.
Figure 5. RT-PCR analysis of ospA from Bb in ticks after 72 h of tick
feeding. RNAs were exacted from ticks forcibly removed from mice in-
fected with either wild-type Bb (WT) or the OspA/B  mutant.   and  ,
the presence or absence, respectively, of reverse transcriptase in the RT-
PCR reactions.
Figure 6. Strategy for transcom-
plementation of the OspA/B  mu-
tant. (A) Diagram of the shuttle vector
pOspA/B used for complementa-
tion. (B) SDS-PAGE (Coomassie
blue stain) and (C) immunoblot of
whole cell lysates of Bb strains. For
immunoblotting, antibodies directed
against OspA and OspB were
pooled. Lanes 1, wild-type Bb; lanes
2, the OspA/B  mutant; lanes 3, the
OspA/B  mutant complemented
with pOspA/B.Function of OspA 646
sible to deliver an equal number of mutant or wild-type
spirochetes with 100% efficiency into sterile nymph mid-
guts by direct microinjection into tick rectums. A relatively
large number (104) of spirochetes per tick also can be intro-
duced, such that colonization could be visualized at a time
point (24 h) earlier than was possible via natural tick feed-
ing (72 h) and that presumably preceded loss of spirochete
viability. Microinjected nymphs then were allowed to feed
on naive mice. At 24 h of tick feeding, spirochetes in the
blood meals of ticks harboring either wild-type 297 or the
OspA/B  mutant were abundant and comparable, whereas
wild-type spirochetes but not the OspA/B  mutant were
found associated with tick midgut tissues (see Fig. 7). In ad-
dition, ticks containing wild-type 297 were able to transmit
their spirochetes to uninfected mice but ticks harboring the
OspA/B  mutant were not. We conclude from these data
that the OspA/B  mutant cannot colonize and survive
within tick midgut tissues and therefore cannot complete
the transmission cycle.
To confirm in the context of “molecular” Koch’s pos-
tulates (23) that the loss of ospAB expression accounted for
the inability of the OspA/B  mutant to colonize tick
midgut tissues, we constructed a strain of the mutant com-
plemented in trans with a wild-type copy of the ospAB
operon on a shuttle plasmid (Fig. 6 A). Expression of
OspA and OspB was readily restored in this comple-
mented strain (OspA/B    pOspA/B) (Fig. 6, B and C).
Again taking advantage of the tick microinjection ap-
proach, we observed that in contrast to the OspA/B  mu-
tant, the transcomplemented strain readily colonized tick
midgut tissues (Fig. 7, A and B). To examine whether the
ospA gene alone (i.e., in the absence of ospB) could com-
plement the colonization defect, the mutant also was
transformed with a shuttle plasmid harboring a wild-type
copy of ospA. As shown in Fig. 7 B, ospA function also
was able to restore the midgut colonization phenotype to
the OspA/B  mutant.
Of additional potential relevance to our study, naturally
occurring Borrelia variants, ostensibly Bb that lack lp54 en-
coding the ospAB operon, occasionally have been isolated
from unfed and feeding I. scapularis or I. dentatus ticks (24).
The existence in nature of such OspA/B  variants of Borre-
lia seemingly contradicts our findings that OspA/B func-
tion is vital for Bb colonization and survival in ticks in the
wild. To assess the behavior of such an OspA/B  variant in
ticks, strain 48081 (lacking lp54) (24) also was microin-
jected into nymphs. Like our OspA/B  mutant, strain
48081 was readily detected within the blood meal but was
unable to colonize tick midgut tissue (Fig. 7). The paradox
that strain 48081 was isolated from wild ticks (24) but was
unable to colonize ticks in our experiments may be ex-
plained by the fact that such isolates were obtained after
growth in semisolid medium, a method prone to inducing
plasmid loss in Bb. Moreover, such isolates are unable to in-
fect laboratory mice (24), calling into question their rele-
vance overall as natural agents of Lyme borreliosis.
Summary and Implications. The complex enzootic life
cycle of Bb can be envisioned to occur in distinct substages.
Figure 7. Detection of spirochetes in I.
scapularis nymphs microinjected with either
wild-type 297 (WT), the OspA/B  mutant,
the OspA/B  mutant complemented with
ospAB or ospA, or strain 48081 (lacking lp54
encoding the ospAB operon). (A) Confocal
immunofluorescence microscopy. Microin-
jected ticks were allowed to feed on naive
mice; samples collected at 24 h after the onset
of feeding were prepared as described in
Fig. 4 legend. Red denotes tick tissues or
blood cells; green indicates spirochetes.
(B) Quantitative assessment (relative Bb
number per microscope field) of data shown
in A. pOspA/B, the OspA/B  mutant
complemented with the ospAB genes.
pOspA, the OspA/B  mutant comple-
mented with ospA. Binding of wild-type
(WT) Bb was considered as the 100% value.Yang et al. 647
Upon first feeding of sterile tick larvae on Bb-infected
(white-footed) mice, spirochetes colonize the tick midgut.
A resident Bb population persists there as the larval forms
molt into nymphs. Infected nymphs then take a second
blood meal in the Spring of the following year, whereupon
Bb replicates, emigrates from the midgut to the salivary
glands, and then is deposited into the intended (mice, deer)
or unintended (human) host (2). Our data demonstrate an
essential role for OspA/B in tick colonization by Bb. Fur-
thermore, results from genetic complementation studies
(Fig. 7 B) suggest that adherence and colonization of Bb to
tick midgut tissue is mediated largely, if not solely, by
OspA. Our additional surprising finding that the OspA/B 
mutant was unable to survive in tick midguts suggests that
adherence to tick midgut cells also is crucial for some as yet
unknown aspect(s) of spirochete survival. Nonetheless, the
blockage in attachment of Bb to tick midgut tissue and sub-
sequent loss of spirochete viability effectively obstructs all
subsequent downstream transmission events, thereby dis-
rupting the entire enzootic transmission cycle of Bb.
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